|
Day 2
|
|
Tuesday, 11 December, 2012
|
|
10:00 -
10:30
|
Reimbursement and financing models for mobile and connected health
|
- Understanding global healthcare reimbursement landscapes and their evolving approaches to connected health care
- Learning how to develop the evidence that that will be needed by payers to enable future large scale funding of mHealth and telehealth
- Case study – Developing a reimbursement framework for Connected Health in Germany
|
|
|
|
|
10:30 -
11:00
|
|
|
11:00 -
11:30
|
Case study: Innovative connected health options for developing health systems
|
- Using connected technology to enable access to healthcare for millions from the world poorest communities
- Investing in the development of mobile and connected health infrastructures as an alternative to traditional models of care delivery
- Exploring a range of developing mHealth and telehealth implementation projects in the developing world
- Competition winning case study
|
|
|
|
|
11:30 -
12:00
|
|
|
12:00 -
12:30
|
Developing a consumer mobile health business in emerging economies
|
- Examining the potential for the development of scalable consumer mHealth businesses in a developing health systems
- Understanding health funding mechanisms in the world’s poorest countries
- Emerging fee for service models in developing economies – exploring the potential for solutions providers to sell directly to consumers
|
|
|
|
|
12:30 -
13:00
|
Using mobile and connected health solutions for workplace wellness
|
- Providing people with the tools and information they need to manage their own health and well-being
- Using connected solutions as tools within workplace employee wellness systems
- Examining the benefits gained and measuring the impact of mHealth within a workplace setting
|
|
|
|
|
13:00 -
14:00
|
|
|
14:00 -
15:00
|
Evidence and best practice session: Diabetes management
|
-
Examining the evidence to date of the impact of remote monitoring in diabetes management on clinical outcomes
- Developing an analysis of the cost savings available from the effective delivering of remote monitoring in diabetes
- Reviewing the available technologies
- Making it work on the ground and overcoming organisational barriers – best practice implementation guidance
|
|
|
|
|
15:00 -
15:30
|
Using connected solutions to enhance the value of medicines
|
-
Developing the capability to dramatically improve the management of medicines and improve outcomes for patients
- Adding value to medicines though connected health – opportunities for life sciences businesses
- Examining the latest developments in smart pill technology
- Exploring innovations at the intersection of connected health and personalised medicines
|
|
|
|
|
15:30 -
16:00
|
|
|
16:00 -
17:00
|
Evidence session: Connected solutions for respiratory disease and COPD
|
- Examining the evidence to date of the impact of the implementation of remote monitoring for respiratory disease and COPD on clinical outcomes
- Developing an analysis of the cost savings available from the effective delivering of remote monitoring in COPD
- Reviewing the available technologies
- Making it work on the ground and overcoming organisational barriers – best practice implementation guidance
|
|
|
|
|
|
17:00
|
|
